Sullivan, S. D., Bailey, T. S., Roussel, R., Zhou, F. L., Bosnyak, Z., Preblick, R., . . . Blonde, L. (2018). Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study. Diabetes Obes Metab.
Citação norma ChicagoSullivan, Sean D., Timothy S. Bailey, Ronan Roussel, Fang Liz Zhou, Zsolt Bosnyak, Ronald Preblick, Jukka Westerbacka, Rishab A. Gupta, and Lawrence Blonde. "Clinical Outcomes in Real‐world Patients With Type 2 Diabetes Switching From First‐ to Second‐generation Basal Insulin Analogues: Comparative Effectiveness of Insulin Glargine 300 Units/mL and Insulin Degludec in the DELIVER D+ Cohort Study." Diabetes Obes Metab 2018.
Citação norma MLASullivan, Sean D., et al. "Clinical Outcomes in Real‐world Patients With Type 2 Diabetes Switching From First‐ to Second‐generation Basal Insulin Analogues: Comparative Effectiveness of Insulin Glargine 300 Units/mL and Insulin Degludec in the DELIVER D+ Cohort Study." Diabetes Obes Metab 2018.